- Molecular NamePheniramine
- Synonym1-Phenyl-1-(2-pyridyl)-3-dimethylaminopropane; 2-(3-Dimethylamino-1-phenylpropyl)pyridine; 2-(alpha-(2-Dimethylaminoethyl)benzyl)pyridine; 2-[; alpha; -(2-Dimethylaminoethyl)benzyl]pyridine; 2-[; alpha; -[2-(Dimethylamino)ethyl]benzyl]pyridine; Dimethyl(3-phenyl-3-(2-pyridyl)propyl)amine; Feniramina [inn-spanish]; Feniramine; Pheniraminum [inn-latin]; Propheniramine; Prophenpyridamine
- Weight240.35
- Drugbank_IDDB01620
- ACS_NO86-21-5
- Show 3D model
- LogP (experiment)2.02
- LogP (predicted, AB/LogP v2.0)2.56
- pka4.2, 9.3 (25°)
- LogD (pH=7, predicted)0.41
- Solubility (experiment)Insoluble
- LogS (predicted, ACD/Labs)(ph=7)-0.08
- LogSw (predicted, AB/LogsW2.0)1.85
- Sw (mg/ml) (predicted, ACD/Labs)1.05
- No.of HBond Donors0
- No.of HBond Acceptors2
- No.of Rotatable Bonds5
- TPSA16.13
- StatusFDA approved
- AdministrationN/A
- PharmacologyAn antihistamine used to treat allergic conditions such as hay fever or urticaria.
- Absorption_value99.0
- Absorption (description)N/A
- Caco_2N/A
- Bioavailability99.0
- Protein bindingN/A
- Volume of distribution (VD)3.3 L/kg
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmHepatic hydroxylation, demethylation and glucuronidation
- Half lifeN/A
- ExcretionRenal
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityN/A
- LD50 (rat)N/A
- LD50 (mouse)N/A